Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings-Reference-Cited by-同舟云学术

Suboptimal Clinical Response Rates with Newer Antibiotics Among Patients with Moderate Renal Impairment: Review of the Literature and Potential Pharmacokinetic and Pharmacodynamic Considerations for Observed Findings

Published:2018-11-09 Issue:12 Volume:38 Page:1205-1215
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Bidell Monique R.¹,Lodise Thomas P.¹^ORCID

Affiliation:

1. Albany College of Pharmacy and Health Sciences Albany New York

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2184

Reference26 articles.

1. Exposure‐Response Working Group.Guidance for Industry: Exposure‐response relationships—study design data analysis and regulatory applications. US Department of Health and Human Services April 2003. Available fromhttps://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm072109.pdf. Accessed June 28 2018.

2. Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program

3. Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)

4. The Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-Structure Infections

5. Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureus

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceftazidime-avibactam induced renal disorders: past and present;Frontiers in Pharmacology;2024-01-22

2. Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams;Expert Review of Anti-infective Therapy;2023-01-31

3. Estimated glomerular filtration rate with and without race for drug dosing: Cystatin C vs . serum creatinine;British Journal of Clinical Pharmacology;2022-11-29

4. Clinical efficacy of renal dosing adjustments of ceftazidime–avibactam in patients affected by carbapenem‐resistant Gram‐negative infections: A systematic review and meta‐analysis of observational studies;British Journal of Clinical Pharmacology;2022-11-22

5. Drug Regimens of Novel Antibiotics in Critically Ill Patients with Varying Renal Functions: A Rapid Review;Antibiotics;2022-04-20